178 related articles for article (PubMed ID: 1720488)
21. Sleep disturbances in hypertension: a double-blind study between isradipine and metoprolol.
Kantola I; Rauhala E; Erkinjuntti M; Mansury L
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S41-5. PubMed ID: 1720486
[TBL] [Abstract][Full Text] [Related]
22. Once-daily monotherapy with trandolapril in the treatment of hypertension.
Smith DH; Neutel JM; Black HR; Schoenberger JA; Weber MA
J Hum Hypertens; 1996 Feb; 10(2):129-34. PubMed ID: 8867568
[TBL] [Abstract][Full Text] [Related]
23. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
[TBL] [Abstract][Full Text] [Related]
24. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
Burger KJ; Dehner R
Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
26. Effects of the calcium antagonist isradipine on 24-hour ambulatory blood pressure, platelet aggregation, and neutrophil oxygen free radicals in hypertension.
Ding YA; Han CL; Chou TC; Lai WY; Shiao MF
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S32-7. PubMed ID: 1376832
[TBL] [Abstract][Full Text] [Related]
27. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
Lohmann FW; Welzel D; Burger KJ
Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
[TBL] [Abstract][Full Text] [Related]
28. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension.
Meriç M; Gören T; Atilgan D; Eren N; Cubukçu A; Koylan N
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S58-60. PubMed ID: 1376837
[TBL] [Abstract][Full Text] [Related]
29. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[TBL] [Abstract][Full Text] [Related]
30. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure.
Portaluppi F; Vergnani L; Manfredini R; degli Uberti EC; Fersini C
Am J Hypertens; 1995 Jul; 8(7):719-26. PubMed ID: 7546498
[TBL] [Abstract][Full Text] [Related]
31. Isradipine in the treatment of mild to moderate essential hypertension.
Leary WP; Maharaj B; Van der Byl K
S Afr Med J; 1991 Oct; 80(7):322-3. PubMed ID: 1833834
[TBL] [Abstract][Full Text] [Related]
32. [The prolonged-action form of Lomir (isradipine) in the treatment of mild and moderate essential hypertension].
Dmitriev VV; Arabidze GG; Epifanova ON; Rogoza AN; Metelitsa TV; Mychka VB
Ter Arkh; 1996; 68(9):35-7. PubMed ID: 9005609
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure effects of the angiotensin II receptor blocker, losartan.
Weber MA; Byyny RL; Pratt JH; Faison EP; Snavely DB; Goldberg AI; Nelson EB
Arch Intern Med; 1995 Feb; 155(4):405-11. PubMed ID: 7848024
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
Johnson AG; Pearce GL; Danoff TM
J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
[TBL] [Abstract][Full Text] [Related]
35. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
Christensen HR; Kampmann JP; Simonsen K
J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
[TBL] [Abstract][Full Text] [Related]
36. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the antihypertensive efficacy of isradipine SRO as assessed by ambulatory blood pressure determination].
Waeber B; Soret P; Poget PN; Brunner HR
Schweiz Rundsch Med Prax; 1992 Dec; 81(50):1514-7. PubMed ID: 1465521
[TBL] [Abstract][Full Text] [Related]
38. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
39. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
Hermans L; Bogaert M; Degaute JP; Rorive G; Six R; Bara L; Lanssiers P; De Keyser P; Westelinck KJ
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S38-45. PubMed ID: 1376833
[TBL] [Abstract][Full Text] [Related]
40. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
Amodeo C; Barros LM; Batlouni M; Sousa JE
Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
